-transparent.png){kind=logo}
Efficiency of pulse-therapy with prospidin (500 mg for 5 days in hospital, 500-1000 mg for a month as maintenance) and methotrexate (30 mg a week i.v. in hospital, 7-10 mg a week as maintenance) was investigated in 93 patients with severe RA. The response to prospidin and methotrexate arose quickly (within 10-14 and 4-5 weeks, respectively) and occurred in 73 and 70% of patients, respectively. Withdrawal of the drug was caused by side effects of methotrexate (19.3%) and resistance to prospidin (23.2%).
Related Publications
B F Nemtsov, and
E V Benenson, and
O V Timina
December 1987,
Annals of internal medicine,
B F Nemtsov, and
E V Benenson, and
O V Timina
June 1988,
Annals of internal medicine,
B F Nemtsov, and
E V Benenson, and
O V Timina
December 2003,
Rheumatology (Oxford, England),
B F Nemtsov, and
E V Benenson, and
O V Timina
January 1980,
The Journal of rheumatology,
B F Nemtsov, and
E V Benenson, and
O V Timina
January 1992,
Terapevticheskii arkhiv,
B F Nemtsov, and
E V Benenson, and
O V Timina
March 1994,
Clinical rheumatology,
B F Nemtsov, and
E V Benenson, and
O V Timina
August 1982,
La Nouvelle presse medicale,
B F Nemtsov, and
E V Benenson, and
O V Timina
January 2005,
Terapevticheskii arkhiv,
B F Nemtsov, and
E V Benenson, and
O V Timina
January 1990,
Terapevticheskii arkhiv,
B F Nemtsov, and
E V Benenson, and
O V Timina
January 1992,
Terapevticheskii arkhiv,
